XML 103 R51.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
CONDENSED STATEMENTS OF OPERATIONS        
Product revenue       $ 628,246
Cost of goods sold       458,675
Gross profit       169,571
Operating expenses:        
Research and development $ 1,720,488 $ 965,308 $ 4,972,881 5,278,768
Marketing and advertising 1,115,639 2,204,979 2,714,421 3,271,600
General and administrative 1,059,938 600,665 2,925,845 1,896,839
Total operating expenses 3,896,065 3,770,952 10,613,147 10,447,207
Loss from operations (3,896,065) (3,770,952) (10,613,147) (10,277,636)
Other income (expense):        
Change in fair value of warrant liability 2,523 (739,306) (3,431,865) (1,563,439)
Interest income and other, net 34,820 5,599 98,065 26,107
Total other income (expense), net 37,343 (733,707) (3,333,800) (1,537,332)
Net loss before taxes (3,858,722) (4,504,659) (13,690,947) (11,814,968)
Income taxes     0 0
Net loss $ (3,858,722) $ (4,504,659) $ (13,690,947) $ (11,814,968)
Basic loss per common share $ (0.40) $ (0.47) $ (1.42) $ (1.22)
Diluted loss per common share $ (0.40) $ (0.47) $ (1.42) $ (1.22)
Weighted-average number of basic shares outstanding 9,673,870 9,673,870 9,673,870 9,673,870
Weighted-average number of diluted shares outstanding 9,673,870 9,673,870 9,673,870 9,673,870